# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.
Keybanc analyst Matthew Gillmor maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $13...
Encompass Health (NYSE:EHC) affirms FY2025 Adj EPS guidance from $5.12-$5.34 to $5.12-$5.34 vs $5.28 analyst estimate. Affirms ...
B of A Securities analyst Kevin Fischbeck maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from ...